Delivery Order SPE2DB20D3303-SPE2DB25FA1JC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,373.08 to AmerisourceBergen Drug Corp for RYTARY ER 36.25 mg-145 mg capsules (100 count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and is being performed at the contractor's Conshohocken, Pennsylvania location. RYTARY is a specialized neurological medication used in the treatment of Parkinson's disease, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $13,503.12 to AmerisourceBergen Drug Corp for RYTARY ER 23.75 mg-95 mg capsules (100-count supply) on August 8, 2025, with completion expected by August 11, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RYTARY is a combination medication used in the treatment of Parkinson's...
- The Defense Logistics Agency awarded a $4,956.93 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of RYTARY ER 23.75 mg-95 mg capsules (100-count units). The order, which represents no set-aside designation and is due for completion by August 11, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,559.33 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of RYTARY ER 36.25 mg–145 mg capsules (100-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $3,565.50 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of RYTARY ER (extended-release carbidopa-levodopa) 36.25 mg-145 mg capsules in a quantity of 100 units. The delivery order is issued under a firm fixed-price contract with an ultimate completion date of July 21, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award includes no set-aside designation and was awarded...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.46 to AmerisourceBergen Drug Corp for RYTARY ER 48.75 mg-195 mg capsules (100-count supply) on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this...
- The Defense Logistics Agency awarded a $4,741.86 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for Rytary ER 48.75 mg-195 mg capsules (100-count supply). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 6, 2025. The contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and represents a child delivery order under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,742.38 to AmerisourceBergen Drug Corp for Rytary ER 48.75 mg-195 mg capsules (100-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. Rytary is a carbidopa-levodopa extended-release medication used to treat Parkinson's disease...
- The Defense Logistics Agency awarded a delivery order valued at $44,283.84 to AmerisourceBergen Drug Corp for the supply of RYTARY ER (extended-release carbidopa-levodopa) 36.25 mg-145 mg capsules in a quantity of 100 units. The contract is a firm fixed price delivery order with an ultimate completion date of June 9, 2025, and was awarded on June 6, 2025 without any set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,102.87 to AmerisourceBergen Drug Corp for RYTARY ER 48.75 mg–195 mg capsules (100 count) on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1JCDelivery Order
The Defense Logistics Agency awarded a $10,505.12 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of RYTARY ER 36.25 mg-145 mg capsules (100-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 15, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. RYTARY ER is a sustained-release formulation of levodopa-carbidopa used in Parkinson's disease treatment, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing procurement of specialized neurological pharmaceuticals for military healthcare systems. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive pharmaceutical support vehicle enabling the contractor to supply medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement requirements through competitively awarded contracts with the Defense Logistics Agency, demonstrating consistent capability to meet the medical supply needs of the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 7/14/25 |